We are live on ! Find out more
NHC

Nicholas Hoffman & Company Portfolio holdings

AUM $4.74B
1-Year Est. Return 18.12%
This Fund
S&P 500
This Quarter Est. Return
+6.31%
1 Year Est. Return
+18.12%
3 Year Est. Return
+65.12%
5 Year Est. Return
+53.27%
10 Year Est. Return
+210.2%
AUM
$255M
AUM Growth
+$17.4M
Cap. Flow
+$3.23M
Cap. Flow %
1.27%
Top 10 Hldgs %
40.98%
Holding
173
New
9
Increased
70
Reduced
65
Closed
7

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$639K
2
CVX icon
Chevron
CVX
+$538K
3
GSK icon
GSK
GSK
+$425K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$359K
5
TSM icon
TSMC
TSM
+$339K

Sector Composition

Rank Sector Weight
1 Consumer Staples 12%
2 Technology 10.83%
3 Financials 9.85%
4 Healthcare 7.55%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEM icon
101
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$546K 0.21%
11,578
+160
+1% +$7.4K
NLY icon
102
Annaly Capital Management
NLY
$17.4B
$542K 0.21%
11,386
-204
-2% -$9.68K
TSM icon
103
TSMC
TSM
$2.18T
$535K 0.21%
13,495
-8,370
-38% -$339K
UN
104
DELISTED
Unilever NV New York Registry Shares
UN
$528K 0.21%
9,371
+300
+3% +$17.3K
RTN
105
DELISTED
Raytheon Company
RTN
$524K 0.21%
2,789
+83
+3% +$15.5K
GPC icon
106
Genuine Parts
GPC
$18.7B
$478K 0.19%
5,030
+2
+0% +$183
CHKP icon
107
Check Point Software Technologies
CHKP
$13.1B
$469K 0.18%
4,530
UNH icon
108
UnitedHealth
UNH
$370B
$462K 0.18%
2,096
-7
-0.3% -$1.48K
BA icon
109
Boeing
BA
$185B
$459K 0.18%
1,556
+163
+12% +$44.1K
XPH icon
110
State Street SPDR S&P Pharmaceuticals ETF
XPH
$508M
$448K 0.18%
+10,289
New +$438K
SCZ icon
111
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.7B
$446K 0.18%
6,916
-1,631
-19% -$103K
GOOGL icon
112
Alphabet (Google) Class A
GOOGL
$4.33T
$433K 0.17%
8,220
+20
+0.2% +$1.03K
IJH icon
113
iShares Core S&P Mid-Cap ETF
IJH
$127B
$379K 0.15%
9,995
+2,510
+34% +$92.8K
GIS icon
114
General Mills
GIS
$19.7B
$377K 0.15%
6,356
-370
-6% -$20K
IVZ icon
115
Invesco
IVZ
$13.9B
$373K 0.15%
10,198
AAXJ icon
116
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.77B
$368K 0.14%
4,826
+317
+7% +$23.9K
HRL icon
117
Hormel Foods
HRL
$13.8B
$365K 0.14%
10,020
-2,276
-19% -$76.5K
HON icon
118
Honeywell
HON
$78B
$359K 0.14%
+2,594
New +$348K
ING icon
119
ING
ING
$102B
$352K 0.14%
+19,064
New +$350K
CADE
120
DELISTED
Cadence Bank
CADE
$347K 0.14%
+11,018
New +$354K
BUD icon
121
AB InBev
BUD
$165B
$346K 0.14%
3,100
+219
+8% +$25.8K
BDX icon
122
Becton Dickinson
BDX
$48.2B
$330K 0.13%
1,579
+3
+0.2% +$628
IWD icon
123
iShares Russell 1000 Value ETF
IWD
$83.7B
$313K 0.12%
2,514
-537
-18% -$65.1K
QQQ icon
124
Invesco QQQ Trust
QQQ
$484B
$311K 0.12%
1,999
-194
-9% -$29.6K
IGSB icon
125
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$310K 0.12%
5,940

Similar funds

Nicholas Hoffman & Company's Q4 2017 Portfolio in Review

As of Q4 2017, Nicholas Hoffman & Company held 173 positions worth $255M, up 7.3% from $237M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Nicholas Hoffman & Company's Q4 2017 filing shows 9 new, 70 increased, 65 reduced and 7 closed positions. Its largest new stake was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K. The largest sale was Walmart Inc, an estimated $639K.

By sector, the portfolio is most concentrated in Consumer Staples at 12% of assets, down from 13% a quarter earlier, followed by Technology and Financials.

  • Nicholas Hoffman & Company's largest Q4 2017 buy was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K.
  • Nicholas Hoffman & Company added most to Vanguard S&P 500 ETF in Q4 2017, an estimated $2.37M increase.
  • Nicholas Hoffman & Company's biggest Q4 2017 reduction was Walmart Inc, cutting an estimated $639K.
  • Nicholas Hoffman & Company fully exited Celgene Corp in Q4 2017, selling an estimated $260K.
  • Nicholas Hoffman & Company's ten largest holdings make up 41% of its $255M portfolio in Q4 2017.
  • Nicholas Hoffman & Company opened 9 new positions and closed 7 in Q4 2017.
  • Nicholas Hoffman & Company's portfolio value rose 7.3% quarter-over-quarter to $255M.

Based on Nicholas Hoffman & Company's 13F filing for Q4 2017, filed 9 Feb 2018.